• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Clinical trials - Articles and news items

cover

Social media sourced Real World Evidence: A new wave in collecting data

Blog, Z Homepage promo / 3 October 2016 / Peter Brady, CEO Orbital Media and Dr Martin Goldman, independent medical officer, Iatros Consulting

Dr Martin Goldman joins Peter Brady, Orbital Media’s CEO, to discuss how to untap the potential of social media sourced real world evidence…

HB-101

First-in-human study of CMV vaccine HB-101 starts

Industry news / 20 July 2016 / Victoria White, Digital Content Producer

Hookipa Biotech has announced the start of a first-in-human study to evaluate the safety and immunogenicity of HB-101 against human cytomegalovirus…

adcetris

Five-year data from Phase II trial of Adcetris published

Industry news / 19 July 2016 / Victoria White, Digital Content Producer

The data comes from a Phase II trial of Adcetris (brentuximab vedotin) in patients with relapsed or refractory classical Hodgkin lymphoma…

edo-s101

First-in-human trial of MundiPharma’s EDO-S101 starts

Industry news / 14 July 2016 / Victoria White, Digital Content Producer

A first in class, fusion molecule, S101 is currently being developed for the treatment of relapsed-refractory haematological malignances…

vxm01

First patient treated in Phase I VXM01 glioblastoma trial

Industry news / 13 July 2016 / Victoria White, Digital Content Producer

Vaximm’s VXM01 is a oral T-cell immunotherapy that targets the tumour-specific vasculature and certain immune-suppressive cells…

PLX-R18

Pluristem contracts CRO for Phase I trial of PLX-R18

Industry news / 12 July 2016 / Victoria White, Digital Content Producer

The Phase I trial will evaluate the safety of intramuscular injections of PLX-R18 cells in 30 patients with incomplete haematopoietic recovery…

RVT-101

Trial of RVT-101 in Alzheimer’s disease starts at Plymouth Science Park

Industry news / 11 July 2016 / Victoria White, Digital Content Producer

If approved, RVT-101 could be the first Alzheimer’s treatment in 14 years. The last drug to be approved to help improve cognition was Donepezil in 2002…

sutent

Positive trial results for Sutent as adjuvant therapy in RCC

Industry news / 8 July 2016 / Victoria White, Digital Content Producer

The S-TRAC study of Sutent versus placebo in the adjuvant setting met its primary endpoint of improving disease-free survival in renal cell carcinoma…

biosimilar etanercept

Sandoz announces EGALITY trial results for biosimilar etanercept

Industry news / 7 July 2016 / Victoria White, Digital Content Producer

The EGALITY study involved 531 patients and compared the efficacy and safety of biosimilar etanercept with the originator product, Enbrel…

ovarian cancer

Phase III trial to evaluate avelumab as first-line treatment in ovarian cancer

Industry news / 6 July 2016 / Victoria White, Digital Content Producer

Avelumab will be evaluated in combination with, and/or as follow-on treatment to, platinum-based chemotherapy in patients with epithelial ovarian cancer…

yeliva

Positive results for Yeliva in Phase I advanced solid tumour study

Industry news / 4 July 2016 / Victoria White, Digital Content Producer

Yeliva is a first-in-class, orally-administered sphingosine kinase-2 (SK2) selective inhibitor with anticancer and anti-inflammatory activities…

follitropin delta

Ferring announces data from its Phase III ESTHER trials

Industry news / 4 July 2016 / Victoria White, Digital Content Producer

ESTHER-1 assessed an individualised dosing regimen of follitropin delta compared to follitropin alfa in women undergoing their first cycle of IVF…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +